Health and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington.
The Department of Health and Human Services finalized a rule Wednesday that would require drugmakers to disclose a drug’s cost if its price before rebates and discounts is above $35 for a month’s supply or the usual course of therapy.
Drugmakers had started disclosing prices online, with the Pharmaceutical Research and Manufacturers of America urging members to, which discuss different pricing scenarios rather than just the list price. The trade association said the rule would give patients watching TV the false impression that they’re required to pay the full price and that the ads would deter patients from seeking treatment. The group also said the proposal would violate the 1st Amendment by compelling commercial speech.California Inc. Newsletter
Medicare for all would stop Big Pharm from obscene profiteering off of sick people !
Prices is all products should be disclosed on television commercials and print ads.
Good!
MedicareForAll
How about we just get rid of the DRUG commercials.
Will this not just make people feel even more beholden to their insurance overlords? And more afraid of the system change we desperately need?
It's time to stop the pharmaceutical control. We need a compassionate FDA. Why is drugs approved with more side effects than your illness? This madness has to stop for future generations.
F Trump in every single way, haha. Horrible leader, horrible human being, horrible American.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: politico - 🏆 381. / 59 Read more »